Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Clozapine for Cannabis Use in Schizophrenia (CLOCS)

This study is currently recruiting participants. (see Contacts and Locations)
Verified September 2016 by Dartmouth-Hitchcock Medical Center
Sponsor:
Collaborators:
University of South Carolina
Michigan State University
University of Miami
University of Massachusetts, Worcester
Information provided by (Responsible Party):
Dartmouth-Hitchcock Medical Center
ClinicalTrials.gov Identifier:
NCT01639872
First received: July 11, 2012
Last updated: September 19, 2016
Last verified: September 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: June 2018
  Estimated Primary Completion Date: December 2017 (Final data collection date for primary outcome measure)